Consolidated Statement Of Income

SymBio Pharmaceuticals Limited - Filing #7272884

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Consolidated statement of income
Statement of income
Net sales
2,452,912,000 JPY
2,452,912,000 JPY
5,589,708,000 JPY
5,589,708,000 JPY
Cost of sales
579,723,000 JPY
579,723,000 JPY
1,178,694,000 JPY
1,178,694,000 JPY
Operating expenses
Operating expenses - general
Remuneration for directors (and other officers)
151,750,000 JPY
151,750,000 JPY
130,414,000 JPY
130,414,000 JPY
Depreciation
JPY
73,302,000 JPY
Operating expenses
Selling, general and administrative expenses
5,750,161,000 JPY
5,853,103,000 JPY
5,263,120,000 JPY
5,222,681,000 JPY
Operating expenses
Operating profit (loss)
-3,876,971,000 JPY
-3,979,914,000 JPY
-852,107,000 JPY
-811,668,000 JPY
Net sales
Operating expenses
Research and development expenses
3,379,471,000 JPY
3,482,414,000 JPY
2,678,673,000 JPY
2,638,234,000 JPY
Gross profit (loss)
1,873,189,000 JPY
1,873,189,000 JPY
4,411,013,000 JPY
4,411,013,000 JPY
Ordinary profit (loss)
-3,689,435,000 JPY
-3,802,316,000 JPY
-773,822,000 JPY
-736,130,000 JPY
General and administrative expenses
Salaries
Selling, general and administrative expenses
Non-operating income
224,722,000 JPY
214,783,000 JPY
135,537,000 JPY
132,789,000 JPY
Interest income
32,116,000 JPY
32,116,000 JPY
11,972,000 JPY
11,972,000 JPY
Non-operating income
Other
20,282,000 JPY
20,282,000 JPY
3,711,000 JPY
3,711,000 JPY
Extraordinary income
14,298,000 JPY
14,298,000 JPY
101,333,000 JPY
101,333,000 JPY
Cost of sales
Non-operating expenses
Non-operating expenses
37,186,000 JPY
37,186,000 JPY
57,252,000 JPY
57,252,000 JPY
Share issuance costs
19,945,000 JPY
19,945,000 JPY
11,478,000 JPY
11,478,000 JPY
Extraordinary losses
131,820,000 JPY
131,820,000 JPY
560,590,000 JPY
560,590,000 JPY
Impairment losses
131,820,000 JPY
131,820,000 JPY
560,590,000 JPY
560,590,000 JPY
Profit (loss) before income taxes
-3,806,957,000 JPY
-3,919,838,000 JPY
-1,233,079,000 JPY
-1,195,387,000 JPY
Gross profit
Extraordinary income
Income taxes - current
26,523,000 JPY
3,800,000 JPY
8,915,000 JPY
22,700,000 JPY
Income taxes - deferred
JPY
JPY
744,728,000 JPY
744,728,000 JPY
Extraordinary losses
Income taxes
26,523,000 JPY
3,800,000 JPY
753,643,000 JPY
767,429,000 JPY
Profit (loss)
-3,923,638,000 JPY
-3,833,480,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-3,923,638,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
-1,962,817,000 JPY
-1,986,723,000 JPY
-1,986,723,000 JPY
Profit (loss) attributable to non-controlling interests
JPY
JPY
Profit (loss) attributable to owners of parent
-3,833,480,000 JPY
-3,833,480,000 JPY
-3,833,480,000 JPY
-1,962,817,000 JPY
-1,962,817,000 JPY
-1,962,817,000 JPY
Other comprehensive income
Foreign currency translation adjustment
13,879,000 JPY
6,228,000 JPY
Other comprehensive income
13,879,000 JPY
6,228,000 JPY
Profit attributable to
Comprehensive income
-3,819,600,000 JPY
-1,956,588,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
-3,819,600,000 JPY
-1,956,588,000 JPY
Comprehensive income attributable to non-controlling interests
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.